Morphine anticorps

N° du produit ABIN263877

Cet anticorps anti-Morphine Monoclonal Souris (Clone BDI263) (ABIN263877) détecte spécifiquement Morphine dans LF et EIA.

Aperçu rapide pour Morphine anticorps (ABIN263877)

Antigène: Morphine

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Morphine est non-conjugé

Application: Lateral Flow (LF), Enzyme Immunoassay (EIA)

Clone: BDI263

Détail du produit anti-Morphine anticorps

Purification: Protein A chromatography

Immunogène: Morphine-BTG

Isotype: IgG1

Information d'application

Indications d'application: Tested in a rapid test (lateral flow) format.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 2.58mg/mL

Buffer: 0.15 M PBS, pH 7.4 containing 0,09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
Shelf life: one year from despatch.

Date de péremption: 12 months

Détails sur Morphine

Antigène: Morphine

Classe de substances: Chemical

Sujet: Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.